Edition:
United States

Cardiovascular Systems Inc (CSII.OQ)

CSII.OQ on NASDAQ Stock Exchange Global Select Market

30.77USD
10:50am EDT
Change (% chg)

$-0.33 (-1.06%)
Prev Close
$31.10
Open
$31.07
Day's High
$31.11
Day's Low
$30.69
Volume
11,440
Avg. Vol
101,342
52-wk High
$32.51
52-wk Low
$15.71

Latest Key Developments (Source: Significant Developments)

Cardiovascular Systems Q3 loss per share $0.05
Wednesday, 3 May 2017 04:05pm EDT 

May 3 (Reuters) - Cardiovascular Systems Inc ::Cardiovascular Systems Inc reports fiscal 2017 third-quarter financial results.Q3 loss per share $0.05.Q3 revenue $52.1 million versus I/B/E/S view $51.1 million.Q3 earnings per share view $-0.05 -- Thomson Reuters I/B/E/S.Sees q4 2017 loss per share $0.04 to $0.06.Sees q4 2017 revenue $51.5 million to $52.5 million.  Full Article

Cardiovascular Systems updates on former employee case
Wednesday, 26 Apr 2017 10:06am EDT 

April 26 (Reuters) - Cardiovascular Systems Inc :Cardiovascular Systems says jury awarded plaintiff $2.7 million compensatory damages for claims for whistleblower retaliation, wrongful termination.Cardiovascular Systems Inc - Case related to claims made by co's former regional sales manager.Cardiovascular Systems says jury also awarded plaintiff $22.4 million in punitive damages with respect to same claims.Cardiovascular Systems says it is assessing impact of the verdict on its financial results and condition and will provide further updates accordingly.  Full Article

Cardiovascular Systems initiates voluntary recall of saline infusion pump
Monday, 17 Apr 2017 09:15pm EDT 

April 17 (Reuters) - Cardiovascular Systems Inc :Cardiovascular Systems initiates voluntary recall of saline infusion pump.Cardiovascular Systems Inc - initiated a voluntary recall of its 7-10014 saline infusion pump.Cardiovascular Systems says csi expects to record approximately $1.5 million of expenses in its Q3 of fiscal 2017 related to recall and replacement.Says there have been no reports of patient injury to date.Cardiovascular Systems - recall and related charge do not have adverse effect on Q3 revenue and net loss guidance provided by company.Plans to recall and replace approximately 900 units of pumps currently in customer inventory.Cardiovascular Systems - determined electromagnetic interference present in hospital environment may cause pumps to switch to standby mode during use.  Full Article

Cardiovascular Systems receives approval for Diamondback 360 coronary orbital atherectomy system Micro Crown in the United States
Thursday, 30 Mar 2017 08:00am EDT 

Cardiovascular Systems Inc : Cardiovascular Systems, Inc. receives approval for the Diamondback 360® coronary orbital atherectomy system (oas) micro crown in the United States .A limited release of oas micro crown is expected to begin in U.S. later this summer.  Full Article

Cardiovascular Systems reports Q2 earnings per share $0.03
Wednesday, 25 Jan 2017 04:05pm EST 

Cardiovascular Systems Inc : Reports fiscal 2017 second-quarter financial results . Q2 earnings per share $0.03 . Q2 revenue $50 million versus I/B/E/S view $49.6 million . Sees Q3 2017 loss per share $0.04 to $0.06 . Sees Q3 2017 revenue $50.5 million to $51.5 million . Q2 earnings per share view $-0.06 -- Thomson Reuters I/B/E/S .Q3 earnings per share view $-0.05, revenue view $51.9 million -- Thomson Reuters I/B/E/S.  Full Article

Cardiovascular Systems Inc signs distribution agreement with Medikit Co., Ltd
Monday, 14 Nov 2016 06:00am EST 

Cardiovascular Systems Inc : Agreement includes $10 million upfront payment to CSI .Press release - Cardiovascular systems, Inc. signs distribution agreement with Medikit Co., Ltd. for Japan.  Full Article

Cardiovascular Systems names Scott Ward as CEO
Tuesday, 16 Aug 2016 07:00am EDT 

Cardiovascular Systems Inc : Cardiovascular Systems names Scott Ward as CEO . Cardiovascular Systems Inc says Scott R. Ward, company's new chairman and chief executive officer, effective immediately .Scott Ward has been serving as chairman since November 2014 and interim president and CEO since November 2015.  Full Article

Cardiovascular Systems reports Q4 loss per share $0.15
Wednesday, 3 Aug 2016 04:05pm EDT 

Cardiovascular Systems Inc : Q4 revenue $48.5 million versus I/B/E/S view $46 million . Q4 earnings per share view $-0.20 -- Thomson Reuters I/B/E/S . Quarter financial results . Q4 loss per share $0.15 . Sees q1 revenue in a range of $48.0 million to $49.5 million . Sees q1 loss per common share ranging from $0.18 to $0.21 .Q1 earnings per share view $-0.22, revenue view $45.9 million -- Thomson Reuters I/B/E/S.  Full Article

Cardiovascular Systems announces settlement agreement to resolve investigation by DOJ, qui tam complaint filed by Travis Thams
Tuesday, 28 Jun 2016 05:01pm EDT 

Cardiovascular Systems Inc : Settlement agreement with United States of America, to resolve investigation by DOJ, qui tam complaint filed by Travis Thams . Under the settlement agreement, the company will pay $8 million - SEC filing .Will also be required to pay Thams' reasonable expenses, costs and attorney’s fees, which amount has not yet been determined.  Full Article

Class Action Lawsuit Filed Against Cardiovascular Systems Inc - ACSWIR
Monday, 21 Mar 2016 09:02am EDT 

Cardiovascular Systems Inc:The law firm of Kessler Topaz Meltzer & Check, LLP announces that it has filed a shareholder class action lawsuit in the United States District Court for the District of Minnesota against Cardiovascular Systems - ACSWIR.on behalf of purchasers of the Company's common stock between September 12, 2011 and January 21, 2016, inclusive (the "Class Period").The shareholder class action complaint alleges that CSI and certain of its executive officers made a series of false and misleading statements and failed to disclose material adverse facts about the Company's business and operations.Specifically, the defendants are alleged to have falsely touted CSI's code of ethics while failing to disclose that the Company relied upon illegal kickbacks, off-label promotions, and other violations of applicable laws and regulations in order to drive sales of its products.  Full Article

More From Around the Web

BRIEF-Cardiovascular Systems Q3 loss per share $0.05

* Cardiovascular Systems Inc reports fiscal 2017 third-quarter financial results